Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
862.30
Change Change %
-6.45 -0.74%

Updated:18 Jan, 2019, 15:59 PM IST

BSE
859.60
Change Change %
-8.70 -1.00%

Updated:18 Jan, 2019, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Bank of America Merrill Lynch
N/A
24-03-2014 Buy 952.85 1120.00
N/A
Target Hit Long (1Y)
24-03-2015

Bank of America Merrill Lynch maintains buy on Lupin

The launch of Niacin (Vitamin B) with 100-day semi-exclusivity is a positive. Lupin remains top pick in Indian pharma space. Company has highest earnings growth among peers. Target Rs 1120.

Top